Skip to main content

Celltrion says clinical trials show COVID-19 treatment is safe, effective

South Korean pharmaceutical company Celltrion announced that its antibody COVID-19 drug Rekirona is safe and effective after global clinical trials.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.